Evicenter
Mounjaro (tirzepatide) in Type 2 diabetes
Manufacturer
Lilly USA, LLC
Prescribing information
Mounjaro (opens in a new tab)
Questions
37
Last updated

All questions

Safety: Mounjaro (tirzepatide) in type 2 diabetes

9 questions · 3 sources

Side effects

What are the long-term side effects of Mounjaro over 104 weeks (SURPASS-EARLY)?

Applies to Adults with type 2 diabetes diagnosed within 0 to 4 years and inadequately controlled on metformin alone (SURPASS-EARLY)

Note: The adverse event values are from the table description on the clinical data page, whose opening sentence describes the hypoglycemia table; the values match the visible Common Adverse Events Occurring in ≥5% of Patients table. Each percentage is the incidence of the event through week 104. SURPASS-EARLY is not described in the Prescribing Information.

What are the most common side effects of Mounjaro?

Applies to Glycemic control as an adjunct to diet and exercise in adults with type 2 diabetes mellitus

Note: Table 1 columns are placebo, MOUNJARO 5 mg, 10 mg, and 15 mg, in that order (% of patients).

Mounjaro nausea and stomach side effects: how common are they?

Applies to Glycemic control as an adjunct to diet and exercise in adults with type 2 diabetes mellitus

Do Mounjaro stomach side effects like nausea go away over time?

Applies to Glycemic control as an adjunct to diet and exercise in adults with type 2 diabetes mellitus

How can Mounjaro nausea and stomach side effects be reduced?

Note: The eating suggestions are an endocrinologist's counseling advice for pediatric patients in the SURPASS-PEDS video on the pediatric page of the Mounjaro HCP site; they do not appear in the Prescribing Information.

Does Mounjaro cause low blood sugar, especially with insulin or a sulfonylurea?

Applies to Glycemic control as an adjunct to diet and exercise in adults with type 2 diabetes mellitus

Note: Table 2 columns are placebo, MOUNJARO 5 mg, 10 mg, and 15 mg, in that order.

What are the side effects of Mounjaro in children?

Applies to Glycemic control as an adjunct to diet and exercise in pediatric patients 10 years of age and older with type 2 diabetes mellitus

Note: Table 3 columns are placebo, MOUNJARO 5 mg, and 10 mg, in that order. The visible SURPASS-PEDS adverse events table on the pediatric page labels the pooled group n=33 and gives pooled vomiting as 13 (20%) and placebo vomiting as 3 (9%); its table description gives n=65, 9 (14%), and 1 (3%). The label combines abdominal pain and upper abdominal pain, which the site lists separately.

How common are injection site reactions with Mounjaro?

Applies to Glycemic control as an adjunct to diet and exercise in adults with type 2 diabetes mellitus

Does Mounjaro increase heart rate?

Applies to Glycemic control as an adjunct to diet and exercise in adults with type 2 diabetes mellitus